Last 17 quarters of trend data · Healthcare · Medical Supplies & Consumables
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 98.96 | — | 36.39 | 233.21 | 53.54 | 2.53 | 37.18 | 24.37 | 91.75 | 24.90 | 25.92 | 12.69 | — | — | — | — | — | — |
| — | — | -2.1% | +856.9% | -41.6% | -89.8% | +43.4% | +92.0% | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.92 | 1.93 | 1.52 | 1.43 | 1.74 | 1.53 | 1.54 | 1.61 | 1.39 | 1.46 | 1.10 | 1.49 | — | — | — | — | — | — |
| — | +26.5% | -0.9% | -11.1% | +25.1% | +4.9% | +39.5% | +7.8% | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 3.14 | 3.13 | 2.80 | 2.31 | 2.75 | 2.57 | 3.65 | 4.07 | 3.90 | 3.80 | 3.20 | 3.12 | — | — | — | — | — | — |
| — | +22.0% | -23.1% | -43.4% | -29.4% | -32.4% | +13.9% | +30.6% | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | — | 38.80 | 23.36 | — | 108.52 | — | 56.30 | — | 31.32 | 39.88 | 7.72 | 8.83 | — | — | — | — | — | — |
| — | — | -58.5% | — | +246.4% | — | +629.0% | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 8.32 | 87.19 | 14.60 | 18.49 | 2.51 | 15.79 | 15.33 | 18.39 | 16.41 | 11.92 | 11.00 | 9.29 | — | — | — | — | — | — |
| — | +452.0% | -4.8% | +0.6% | -84.7% | +32.4% | +39.4% | +98.0% | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 9.08 | 87.19 | 26.65 | 51.22 | 41.39 | 2.54 | 25.01 | 36.39 | 39.12 | 17.76 | 19.74 | 13.12 | — | — | — | — | — | — |
| — | +3329.9% | +6.6% | +40.7% | +5.8% | -85.7% | +26.7% | +177.3% | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.5% | 54.5% | 58.2% | 54.7% | 49.3% | 56.2% | 54.4% | 53.8% | 53.9% | 56.0% | 54.6% | 58.1% | 56.9% | 58.3% | 57.3% | 56.5% | 49.1% | 59.2% |
| — | -3.0% | +7.1% | +1.6% | -8.6% | +0.4% | -0.5% | -7.4% | -5.2% | -4.0% | -4.6% | +2.8% | +15.8% | -1.5% | — | — | — | — | |
| Operating Margin | 26.2% | 3.5% | 8.2% | 4.0% | 84.0% | 6.5% | 9.9% | 7.3% | 6.6% | 13.2% | 11.7% | 18.9% | 19.9% | 24.3% | 20.1% | 18.2% | 11.2% | 21.5% |
| — | -46.6% | -17.3% | -45.0% | +1181.4% | -50.5% | -15.5% | -61.1% | -67.1% | -45.6% | -41.6% | +4.1% | +78.6% | +13.0% | — | — | — | — | |
| Net Margin | 18.7% | -0.6% | 4.2% | 0.6% | 3.2% | 60.4% | 4.2% | 6.6% | 1.5% | 5.9% | 4.3% | 11.8% | 13.4% | 22.2% | 15.5% | 14.6% | -16.0% | 17.0% |
| — | -101.0% | +0.0% | -90.2% | +111.1% | +930.8% | -2.6% | -43.7% | -88.8% | -73.6% | -72.3% | -19.3% | +183.3% | +30.2% | — | — | — | — |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 38.9% | -0.2% | 1.9% | 0.3% | 1.3% | 29.3% | 2.6% | 4.4% | 1.0% | 4.0% | 2.6% | 3.1% | 3.6% | 6.1% | 2.7% | 2.5% | -2.7% | 2.9% |
| — | -100.9% | -27.7% | -94.1% | +24.6% | +628.5% | -1.6% | +44.2% | -72.4% | -34.4% | -3.2% | +22.4% | +237.3% | +111.3% | — | — | — | — | |
| ROA | 10.8% | -0.1% | 0.6% | 0.1% | 0.4% | 8.7% | 0.6% | 0.9% | 0.2% | 0.8% | 0.6% | 1.7% | 2.0% | 3.3% | 2.4% | 2.2% | -2.3% | — |
| — | -101.0% | +6.8% | -90.3% | +109.9% | +947.6% | +0.1% | -42.9% | -89.1% | -75.1% | -74.2% | -23.1% | +184.1% | — | — | — | — | — | |
| ROIC | 16.9% | 0.5% | 1.4% | 0.6% | 14.2% | 1.1% | 1.5% | 1.1% | 1.0% | 2.0% | 1.7% | 1.8% | 2.0% | 3.3% | 2.6% | 2.3% | 1.4% | 2.7% |
| — | -50.0% | -4.7% | -40.6% | +1346.5% | -46.7% | -13.0% | -40.8% | -50.2% | -39.9% | -35.4% | -20.5% | +42.6% | +20.8% | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.00 | 1.10 | 1.10 | 1.02 | 1.00 | 1.03 | 2.14 | 2.43 | 2.71 | 2.54 | 2.90 | 2.16 | 0.71 | 2.56 | 0.01 | 0.01 | — | — |
| — | +6.5% | -48.6% | -57.9% | -63.2% | -59.4% | -26.0% | +12.5% | +280.3% | -0.8% | +23015.8% | +28670.5% | — | — | — | — | — | — | |
| Debt / EBITDA | 1.89 | 92.53 | 16.83 | 23.52 | 2.81 | 19.91 | 23.26 | 28.16 | 28.01 | 19.88 | 22.03 | 15.97 | 15.23 | 12.85 | 0.27 | 0.17 | — | — |
| — | +364.7% | -27.6% | -16.5% | -90.0% | +0.2% | +5.6% | +76.4% | +83.8% | +54.7% | +8143.2% | +9153.8% | — | — | — | — | — | — | |
| Current Ratio | 1.23 | 1.03 | 1.02 | 1.07 | 1.23 | 1.50 | 1.22 | 1.19 | 1.20 | 1.15 | 1.31 | 1.81 | 1.46 | 1.81 | 1.65 | 0.04 | 1.70 | — |
| — | -31.2% | -16.6% | -10.0% | +2.4% | +29.9% | -6.4% | -34.3% | -17.5% | -36.0% | -20.9% | +4004.7% | -14.3% | — | — | — | — | — | |
| Quick Ratio | 0.89 | 0.72 | 0.74 | 0.75 | 0.89 | 1.14 | 0.86 | 0.85 | 0.84 | 0.83 | 0.96 | 1.33 | 0.96 | 1.23 | 1.02 | 0.04 | 1.04 | — |
| — | -36.6% | -14.0% | -12.5% | +5.4% | +38.2% | -10.6% | -35.7% | -12.1% | -32.7% | -5.7% | +2903.7% | -7.1% | — | — | — | — | — | |
| Interest Coverage | 5.94 | 0.84 | 2.69 | 1.26 | 2.14 | 18.01 | 2.00 | 1.37 | 1.12 | 2.56 | 1.84 | 9.44 | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 17 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SOLV stock.
Solventum Corporation's current P/E is 99.0x. The average P/E over the last 3 quarters is 107.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Solventum Corporation's current operating margin is 26.2%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Solventum Corporation's business trajectory between earnings reports.